Skip to main content

Table 2 Patients’ satisfaction scores at baseline, 3-months, 6-months, 9-months and 12-months follow-ups

From: A non-clinical randomised controlled trial to assess the impact of pharmaceutical care intervention on satisfaction level of newly diagnosed diabetes mellitus patients in a tertiary care teaching hospital in Nepal

Groups

Control group

Test 1 group (PC group)

Test 2 group (PC + Diabetic kit group)

Follow-ups

Median score (IQR)

Median score (IQR)

Median score (IQR)

Baseline

44 [(42)-(46)]

45 [(42)-(46)]

43 [(41)-(46)]

3-months (1st F/U)

50 [(48)-(51)]

66 [(64)-(69)]

68 [(66)-(70)]

6-months (2nd F/U)

49 [(48)-(50)]

67 [(65)-(70)]

69 [(66)-(71)]

9-months (3rd F/U)

49 [(48)-(50)]

68 [(66)-(70)]

69 [(68)-(73)]

12-months (4th F/U)

47.74 [(47)-(48.25)]

68 [(66)-(70)]

73 [(70)-(75)]